Status: current, Defined. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4822521000168112 | Ryeqo 40/1/0.5 (estradiol 1 mg + norethisterone acetate 500 microgram + relugolix 40 mg) tablet, 28 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4822531000168110 | Ryeqo 40/1/0.5 tablet, 28 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4822581000168111 | Ryeqo 40/1/0.5 (oestradiol 1 mg + norethisterone acetate 500 microgram + relugolix 40 mg) tablet, 28 tablets | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ryeqo 40/1/0.5 tablet, 28 | Is a | relugolix 40 mg + estradiol 1 mg + norethisterone acetate 500 microgram tablet, 28 | true | Inferred relationship | Some | ||
| Ryeqo 40/1/0.5 tablet, 28 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Ryeqo 40/1/0.5 tablet, 28 | has TP | Ryeqo 40/1/0.5 | true | Inferred relationship | Some | ||
| Ryeqo 40/1/0.5 tablet, 28 | has TPUU | Ryeqo 40/1/0.5 tablet | true | Inferred relationship | Some | 785082431 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ryeqo 40/1/0.5 tablet, 28, bottle | Is a | True | Ryeqo 40/1/0.5 tablet, 28 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR